ROLE OF TRANEXAMIC ACID IN CONTROLLING BLOOD LOSS IN TOTAL HIP ARTHROPLASTY

Objective: The incidence of total hip arthroplasty (THA) is on the rise, often resulting in significant blood loss. It has been observed that Tranexamic acid (TXA) can diminish the blood loss experienced during the perioperative period of hip joint arthroplasty. Nonetheless, the optimal method of administering TXA remains a topic of debate. So, we studied the role of Tranexamic Acid in Controlling Blood Loss in Total Hip Arthroplasty. Methods: In Prospective group data: By giving a dose of 15 mg/kg of Tranexamic acid, intravenously 15 min before given incision and 15 mg/kg topically after the closure of the hip joint capsule. Retrospective data from the records of previous patients who were administered intravenous tranexamic acid while undergoing THR in the past 3 years with 30 cases in each group. Information was gathered regarding the volume of blood loss, levels of hemoglobin, frequency of transfusions, and the incidence of deep vein thrombosis and pulmonary embolism. Results: The mean operation times were approximately 43.5±9.0 min and 42.2±8.0 min in group A and group B, respectively. The operation time and intra-operative blood loss show insignificant differences in prospective and retrospective groups. The post-operative blood loss, total blood loss, and decrease in haemoglobin level depicted insignificant differences in prospective and retrospective groups. There were insignificant differences in terms of blood loss and systemic complications between tranexamic acid administration methods. Conclusion: Tranexamic acid is effective in minimizing blood loss following surgery as well as the overall blood loss associated with total hip arthroplasty, according to the data reviewed and the results of this study showing non-inferior efficacy of topical TXA and IV TXA with IV TXA, we proposed that topical administration of 15 mg/ml of TXA before wound closure was a simple, safe, feasible and effective prophylactic measure with minimal adverse effects. The use of this method proved to be economical, effectively decreasing bleeding, diminishing the necessity for additional blood transfusions, and averting the possibility of surgical intervention due to excessive bleeding.

Authors

Institutions

Publication Details

Journal
International Journal of Current Pharmaceutical Research
Published
2024-09-15
DOI
https://doi.org/10.22159/ijcpr.2024v16i5.5075
Primary Topic
Blood transfusion and management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ROLE OF TRANEXAMIC ACID IN CONTROLLING BLOOD LOSS IN TOTAL HIP ARTHROPLASTY

Manmohan Shakya, VISHNU PAL, Manish Chauhan, Pinnamaneni Siddhartha et al.
International Journal of Current Pharmaceutical Research
Blood transfusion and management
article

ROLE OF TRANEXAMIC ACID IN CONTROLLING BLOOD LOSS IN TOTAL HIP ARTHROPLASTY

Manmohan Shakya, VISHNU PAL, Manish Chauhan, Pinnamaneni Siddhartha, GAUTAM CHATERJII, SYED T. MAHMOOD
article en

Abstract

Objective: The incidence of total hip arthroplasty (THA) is on the rise, often resulting in significant blood loss. It has been observed that Tranexamic acid (TXA) can diminish the blood loss experienced during the perioperative period of hip joint arthroplasty. Nonetheless, the optimal method of administering TXA remains a topic of debate. So, we studied the role of Tranexamic Acid in Controlling Blood Loss in Total Hip Arthroplasty. Methods: In Prospective group data: By giving a dose of 15 mg/kg of Tranexamic acid, intravenously 15 min before given incision and 15 mg/kg topically after the closure of the hip joint capsule. Retrospective data from the records of previous patients who were administered intravenous tranexamic acid while undergoing THR in the past 3 years with 30 cases in each group. Information was gathered regarding the volume of blood loss, levels of hemoglobin, frequency of transfusions, and the incidence of deep vein thrombosis and pulmonary embolism. Results: The mean operation times were approximately 43.5±9.0 min and 42.2±8.0 min in group A and group B, respectively. The operation time and intra-operative blood loss show insignificant differences in prospective and retrospective groups. The post-operative blood loss, total blood loss, and decrease in haemoglobin level depicted insignificant differences in prospective and retrospective groups. There were insignificant differences in terms of blood loss and systemic complications between tranexamic acid administration methods. Conclusion: Tranexamic acid is effective in minimizing blood loss following surgery as well as the overall blood loss associated with total hip arthroplasty, according to the data reviewed and the results of this study showing non-inferior efficacy of topical TXA and IV TXA with IV TXA, we proposed that topical administration of 15 mg/ml of TXA before wound closure was a simple, safe, feasible and effective prophylactic measure with minimal adverse effects. The use of this method proved to be economical, effectively decreasing bleeding, diminishing the necessity for additional blood transfusions, and averting the possibility of surgical intervention due to excessive bleeding.

International Journal of Current Pharmaceutical Research
People’s University (IN)
Openalex Percentile: Top 86%
Blood transfusion and management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.